Moderna begins testing COVID-19 vaccine on infants and children

OAN Top News

FILE - In this Jan. 10, 2021, file photo home health care workers and their patients start receiving Moderna COVID-19 vaccines at a drive-thru vaccination clinic in Portland, Ore. Oregon health officials and vaccine advisory committee members have made critical, and often controversial, decisions about which groups of people should be prioritized next for the COVID-19 vaccine amid limited supply. Under a new pilot program this week, at least seven federally qualified health centers in Oregon are now able to inoculate whoever they want, even if that patient does not fall into currently eligible categories. (Kristyna Wentz-Graff/Oregon Public Broadcasting via AP, Pool, File)

OAN Newsroom
UPDATED 11:35 AM PT – Tuesday, March 16, 2021

Moderna has started testing its COVID-19 vaccine on infants and children.

According to reports Tuesday, the pharmaceutical company is seeking to expand approval for its vaccine for those between the ages of six months and 12-years-old. The study will consist of nearly 7,000 children in both the U.S. and Canada.

“There will be two parts to this study, the first parts is where we will find the appropriate dose of the vaccine for children,” explained Jacqueline Miller, Moderna’s therapeutic area head for infectious diseases. “Children often need lower doses of vaccines than adults, so we want to make sure we find the best dose that increases their immunity.”

Meanwhile, both Moderna and Pfizer have begun testing on children 12 and older with hopes to make vaccines available to those age groups this year.

MORE NEWS: Whistleblower victimized under Cuomo for a decade

Leave a Reply